Pharmaceutical companies have agreed to pay $ 700 million to the Hawaii to settle the case on the effectiveness and protection of the blood plavix, the State Attorney General Office on Friday.
Last year, a court verdict was ordered to pay $ 916 million to three US-based supporters of the French Pharmaceutical Company and French Pharmaceutical Company Sanophi.
However, before deciding the appeal, a small settlement reached, the Attorney General Office said.
In a joint statement, agencies say “they are pleased to resolve these cases and continue to concentrate on the innovative drugs of patients in discovering, developing and supplying patients.”
The statement also said, “Plavix has assisted millions of people suffering from cardiovascular disease around the world for almost 3 years and it is about to be approved as the first row therapy through the topic of the world,” the statement added.
James Ashford, a judge of the first circuit court, has discovered that about 5% of patients, especially non-Cacacians, have a “reduced response” of plavix, but companies could not update their labels, Attorney General Ann Lopez said last year.
No company acknowledged wrongdoing.
Hawaii Governor. Josh Green called AT “Landmark Settlement” and “Main Victory” for the State.
The Attorney General’s Office said the settlement equally divided $ 700 million between Bristol Myers Squibs and Sanophi, will be paid by the wire transfer by June 9, the Attorney General’s Office said.
Leave a Reply